PKCθ pseudosubstrate peptide inhibitor, myristoylated

PKCθ pseudosubstrate peptide inhibitor, myristoylated is a synthetic peptide that can be used to study the mechanism of action of PKCθ[1].

Product Specifications

UNSPSC

12352209

Target

PKC

Type

Peptides

Related Pathways

Epigenetics; TGF-beta/Smad

Applications

Cancer-Kinase/protease

Field of Research

Others

Assay Protocol

https://www.medchemexpress.com/pkcθ-pseudosubstrate-peptide-inhibitor-myristoylated.html

Solubility

10 mM in DMSO

Smiles

O=C([C@@H](NC(CCCCCCCCCCCCC)=O)CC(C)C)N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(NCC(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N)=O)CS)=O)CCCCN)=O)C(C)C)=O)CC1=CNC=N1)=O)CC2=CNC=N2)=O)C(C)C)=O)CCCCN)=O)C)=O)CCC(N)=O)=O)CCCCN)=O)[C@H](CC)C)=O)C)=O)=O)CCCNC(N)=N)=O)CCCNC(N)=N)=O)CCC(N)=O)=O)CC3=CNC=N3

Molecular Formula

C105H184N36O21S

Molecular Weight

2318.88

References & Citations

[1]Koon HW, et al. Substance P-stimulated interleukin-8 expression in human colonic epithelial cells involves protein kinase Cdelta activation. J Pharmacol Exp Ther. 2005 Sep;314 (3) :1393-400.